Omali Pitiyarachchi

Immensely proud of the achievements of our #ESMOLGP Asia 2023-2024 group. I can’t thank @myESMO enough for the experience and incredible opportunity. This is just the beginning of great things to come. Watch this space!

Great presentation on Social Media use in our @IASLC Academy by @StephenVLiu ! Thanks for your contribution! Important insights! @RManochakian @LuisRaezMD @ElinardouHelena @acmoorephd

15 Posts Not to Miss from ESMO TAT Asia 2025 @myESMO @herbloong @JiaJennyLiu @omalirp @DrYujiUehara @RashidLui @Connie13179 @DocSRJ17 @L_Gil22 @anmwongNZ oncodaily.com/societies/15-p… #Health #Oncology #OncoDaily #Medicine #Cancer @CancerWorldmag

Recovering from #exhausting but #ExtremelyFruitful 4 days of conferences & meetings: @myESMO #AdvancedCourseInEarlyDevelopment and #ESMOTATAsia25 in #hongkong. 4 talks. 4 chairs. We are thrilled to have been host this #inaugural mtg bringing in > 600attendees from across the 🌎…

Rain, hail or typhoon🌧️🌪️ - D3 #ESMOTATAsia25 commenced with Prof Elizabeth Smyth giving an overlook on new ADC constructs-payload innovation; bispecific ADCs; smaller format delivery systems to incr therap window & reduce tox @myESMO 🇭🇰

Pre-typhoon signal 8 night out in #HongKong 🇭🇰 @DrChristinaTeng

Congratulations to my friend @DrYujiUehara from 🇯🇵 for presenting at the oral abstract session - Day 2 #ESMOTATAsia25 in HK. From an initial meeting on Twitter to IRL at @JSMO_official earlier this year! @myESMO

There are few guarantees in life.. one is that a supportive @herbloong will be there to take photographs if you’re presenting @JiaJennyLiu #ESMOTATAsia25 @myESMO

Amazing work presented by @pankajpanda86 led by @TiraTanChia of @dukenus on behalf of @apoddc! So happy to see how #international #collaborations of like-minded #stakeholders can generate meaningful and impactful data. 📈📊🧑‍💻 Thanks everyone for your support!

Wanted to channel @TonyMok9 energy in driving precision onc collab in APAC @IASLC podcast @NarjustFlorezMD @StephenVLiu really captures IPASS story so well - check it out!

Always nice to meet both new friends and old #ESMOTATAsia25 @myESMO

Prof @AyaHelali -precautions/pitfalls in reporting exploratory biomarker analyses (No single guideline addresses this); Prof @herbloong increasing importance of PROs in early phase clin trials incl dose esc decisions-it’s complicated! #ESMOTATAsia25 @myESMO

Early start to Day 2 #ESMOTATAsia25 with some stats! Dr @anmwongNZ on how to report subgroup analyses in RCTs; IPASS as a good eg w good biological rationale; limitations of a priori & exploratory; photos of Prof Mok an added bonus 🤣 @myESMO

Congrats @pankajpanda86 ! Great presentation and example of APAC collaboration. Oral abstract session day 1 #ESMOTATAsia25 @myESMO

Kicking off the “What did we learn from drug development in lung cancer?” session - @mollylisc from Chinese University of HK highlighting the progress in biomarker use #ESMOTATAsia25 @myESMO

What a way to kick off the inaugural #ESMOTATAsia25 @myESMO

Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

Great opportunity for healthcare professionals to hear from ANZGOG co-founder Prof Michael Friedlander AM and a panel of experts as they present key #gynaecologicalcancer highlights from #ASCO25 and discuss what they mean for patient care in Australia. @thelimbiconc

Really proud for @ANZGOG and #APGOT to have been involved with this practice changing study for women with platinum resistant ovarian cancer! @PeterMacCC